Free Trial
OTCMKTS:BPSR

Organicell Regenerative Medicine (BPSR) Stock Price, News & Analysis

Organicell Regenerative Medicine logo
$2.27 -0.18 (-7.35%)
As of 03/11/2025

About Organicell Regenerative Medicine Stock (OTCMKTS:BPSR)

Key Stats

Today's Range
$2.27
$2.43
50-Day Range
$2.45
$3.40
52-Week Range
$0.04
$0.63
Volume
1,414 shs
Average Volume
3.31 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biotech Products Services & Research, Inc. is a clinical-stage biopharmaceutical company. It focuses on the development of biological therapeutics for the treatment of degenerative diseases and to provide other related services. The firm also focuses on processing, distribution and supply of biologically processed cellular and tissue-based products developed from internally based research and development activities and also provides healthcare, anti-aging, and regenerative services. The company was founded by John Goodhew, Albert Mitrani and Maria Ines Mitrani on August 9, 2011 and is headquartered in Miami, FL.

Remove Ads
Receive BPSR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Organicell Regenerative Medicine and its competitors with MarketBeat's FREE daily newsletter.

BPSR Stock News Headlines

Zeo ScientifiX, Inc. (ZEOX)
Trump Orders 'National Digital Asset Stockpile'
Trump Orders ‘National Digital Asset Stockpile’ THIS could be the coin they choose…
Organicell Regenerative Medicine Inc (OCELD)
OCELD Organicell Regenerative Medicine, Inc.
Organicell Announces 1-for-200 Reverse Stock Split
See More Headlines

BPSR Stock Analysis - Frequently Asked Questions

Organicell Regenerative Medicine's stock was trading at $3.11 at the beginning of the year. Since then, BPSR stock has decreased by 27.0% and is now trading at $2.27.
View the best growth stocks for 2025 here
.

Shares of BPSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Organicell Regenerative Medicine investors own include Aurora Cannabis (ACB), NVIDIA (NVDA), 22nd Century Group (XXII), BioNTech (BNTX), Evofem Biosciences (EVFM), Inseego (INSG) and American Lithium (LIACF).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:BPSR
Fax
N/A
Employees
18
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (OTCMKTS:BPSR) was last updated on 3/12/2025 by MarketBeat.com Staff
From Our Partners